Letter: the gap between guidelines and real clinical practice for dysplasia surveillance in inflammatory bowel disease
Open Access
- 1 February 2020
- journal article
- letter
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 51 (4) , 481-482
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Inflammatory bowel disease: estimates from the global burden of disease 2017 studyAlimentary Pharmacology & Therapeutics, 2019
- Systematic review with network meta‐analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2019
- European evidence based consensus for endoscopy in inflammatory bowel diseaseJournal of Crohn's and Colitis, 2013
- Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohortAlimentary Pharmacology & Therapeutics, 2011
- Review article: the relevance of surveillance endoscopy in long-lasting inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2007